San Francisco-based Hinge Health has completed a randomized control trial of its digital care program for chronic knee pain. Results were promising, with users of the digital platform outperforming ...

A 12-week, 177-participant trial of Hinge Health’s at-home digital program for chronic pain relief significantly reduced users’ lower back pain, disability and interest in surgery. The study, led by ...

SAN FRANCISCO--(BUSINESS WIRE)-- Hinge Health, Inc. (HNGE) today announced that its board of directors has authorized a $250 million share repurchase program. “During the first three quarters of 2025, ...

Based in San Francisco, Hinge Health has developed a digital platform that employs artificial intelligence to largely automate the treatment of joint and muscle conditions. The platform is designed to ...

Combined with Hinge Health’s AI-powered exercise therapy program, HingeSelect adds access to high-quality in-person providers for members at up to 50% below PPO rates SAN FRANCISCO--(BUSINESS ...

Hinge Health’s s-1 filing seems to shed a light on DarioHealth’s potential opportunity; With Hinge targeting a potential $3-6B IPO valuation with similar growth metrics, Dario’s comparable 32.9% ...

(RTTNews) - Hinge Health, Inc. (HNGE) on Wednesday announced that its board of directors has authorized a $250 million share repurchase program. "During the first three quarters of 2025, we generated ...

Collaboration Will Promote Best-in-Class Menopause Care for Employers and Members SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health and Midi Health announced a partnership today to address the significant ...

SAN FRANCISCO - Hinge Health, Inc. (NYSE:HNGE) announced on November 10 that its board of directors has authorized a $250 million share repurchase program for its outstanding Class A Common Stock. The ...